Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Pediatric Hem-Onc Fellowship, Pediatrics, Children's Hospital of Philadelphia 2006 - 2009
  • Pediatric Residency, Pediatrics, Children's Hospital of Philadelphia 2003 - 2006
  • M.D., University of Medicine and Dentistry of New Jersey 2003
• 

  Duke Appointment History

  • Associate Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2017 - 2020
  • Assistant Professor in Medicine, Medicine, Hematology, Medicine 2014 - 2020
  • Assistant Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2011 - 2017
  • Medical Instructor in the Department of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2009 - 2011
• 

  Leadership & Clinical Positions at Duke

  • Program Director, Pediatric Fellowship Program
    Clinical Operations Director, Pediatric Hematology/Oncology
    Director, Pediatric Sickle Cell Program
    Director, Inherited Bone Marrow Failure Program
• Research
• 

  Selected Grants

  • PROTOCOL AG348-C-008 Pyruvate Kinase Deficiency Global Longitudinal Registry awarded by Agios Pharmaceuticals, Inc. 2018 - 2026
  • A Phase 2, Multicenter, Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab, with or without Hydroxyurea/Hydroxycarbamide, in Sequential, Descending Age Groups of Pediatric Sickle Cell Disease Patients with Vaso-Occl awarded by Novartis Pharmaceuticals Corporation 2018 - 2025
  • A Phase 3b, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects with Immun awarded by DOVA Pharmaceuticals 2021 - 2025
  • A phase II, open-label, non-controlled, intrapatient dose escalation study to characterize the pharmacokinetics after oral administration of eltrombopag in pediatric patients with refractory, relapsed or treatment naiive severe aplastic anemia or rec awarded by Novartis Pharmaceuticals Corporation 2017 - 2024
  • AG348-C-011 extension study of adult subjects with Pyruvate Kinase Deficiency awarded by Agios Pharmaceuticals, Inc. 2019 - 2024
  • Phase III study of AG-348 in not regulary transfused adult subjects with Pyruvate kinase deficiency awarded by Agios Pharmaceuticals, Inc. 2018 - 2023
  • AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE SAFETY OF RIVIPANSEL (GMI-1070) IN THE TREATMENT OF ONE OR MORE VASOOCCLUSIVE CRISES IN HOSPITALIZED SUBJECTS WITH SICKLE CELL DISEASE awarded by Pfizer, Inc. 2016 - 2021
  • CSA - Pfizer 212511 B5201002 Phase 3 Randomized Multicenter Trial awarded by Pfizer, Inc. 2015 - 2021
  • Education and Mentoring to BRing Access to CarE SCD - EMBRACE SCD awarded by Carolinas HealthCare System 2017 - 2021
  • A Phase 3 Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children awarded by Novartis Pharmaceuticals Corporation 2019 - 2021
  • Transfusion Medicine and Hematology awarded by National Institutes of Health 1975 - 2021
  • ITP-APPS (Immune ThrombocytoPenia Association of Platelet Parameters Study) awarded by Boston Children's Hospital 2019 - 2021
  • Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug): Follow-Up Observational Study II awarded by National Institutes of Health 2017 - 2018
  • ICON 1 awarded by Boston Children's Hospital 2013 - 2017
  • PKD Natural Study awarded by Boston Children's Hospital 2014 - 2017
  • TCD With Transfusions Changing to Hydroxyurea (TWITCH) Closeout awarded by Cincinnati Children's Hospital Medical Center 2014 - 2015
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Al-Samkari, Hanny, Kathryn Addonizio, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A. Thompson, Kevin H. M. Kuo, et al. “The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.” Br J Haematol 192, no. 6 (March 2021): 1092–96. https://doi.org/10.1111/bjh.16724.
       Full Text  Link to Item
    • Niss, Omar, Robert B. Lorsbach, Mikaela Berger, Satheesh Chonat, Morgan McLemore, David Buchbinder, Timothy McCavit, et al. “Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).” Blood Cells Mol Dis 87 (March 2021): 102534. https://doi.org/10.1016/j.bcmd.2020.102534.
       Full Text  Link to Item
    • Rothman, Jennifer A., Jenny L. Stevens, Fabienne L. Gray, and Theodosia A. Kalfa. “How I approach hereditary hemolytic anemia and splenectomy.” Pediatr Blood Cancer 67, no. 11 (November 2020): e28337. https://doi.org/10.1002/pbc.28337.
       Full Text  Link to Item
    • Rothman, Jennifer A. “Osteomyelitis in sickle cell disease: You know it when you see it?” Pediatr Blood Cancer 67, no. 10 (October 2020): e28585. https://doi.org/10.1002/pbc.28585.
       Full Text  Link to Item
    • Hall, B. J., A. J. Reiter, B. R. Englum, J. A. Rothman, and H. E. Rice. “Long-term hematologic and clinical outcomes of splenectomy in children with hereditary spherocytosis and sickle cell disease.” Pediatric Blood and Cancer 67, no. 8 (August 1, 2020). https://doi.org/10.1002/pbc.28290.
       Full Text
    • Al-Samkari, Hanny, Eduard J. van Beers, D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, et al. “Characterization of the severe phenotype of pyruvate kinase deficiency.” Am J Hematol, July 3, 2020. https://doi.org/10.1002/ajh.25926.
       Full Text  Link to Item
    • Rogers, Zora R., Taizo A. Nakano, Timothy S. Olson, Alison A. Bertuch, Winfred Wang, Alfred Gillio, Thomas D. Coates, et al. “Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.” Haematologica 104, no. 10 (October 2019): 1974–83. https://doi.org/10.3324/haematol.2018.206540.
       Full Text  Link to Item
    • Grace, Rachael F., Kristin A. Shimano, Rukhmi Bhat, Cindy Neunert, James B. Bussel, Robert J. Klaassen, Michele P. Lambert, et al. “Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.” Am J Hematol 94, no. 7 (July 2019): 741–50. https://doi.org/10.1002/ajh.25479.
       Full Text  Link to Item
    • Gallagher, Patrick G., Yelena Maksimova, Kimberly Lezon-Geyda, Peter E. Newburger, Desiree Medeiros, Robin D. Hanson, Jennifer Rothman, et al. “Aberrant splicing contributes to severe α-spectrin-linked congenital hemolytic anemia.” J Clin Invest 129, no. 7 (April 30, 2019): 2878–87. https://doi.org/10.1172/JCI127195.
       Full Text  Link to Item
    • Beers, Eduard J. van, Stephanie van Straaten, D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, et al. “Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.” Haematologica 104, no. 2 (February 2019): e51–53. https://doi.org/10.3324/haematol.2018.196295.
       Full Text  Link to Item
    • Allen, T. M., L. M. Anderson, S. M. Brotkin, J. A. Rothman, and M. J. Bonner. “Computerized Cognitive Training in Pediatric Sickle Cell Disease: A Randomized Controlled Pilot Study.” Clinical Practice in Pediatric Psychology, January 1, 2019. https://doi.org/10.1037/cpp0000313.
       Full Text
    • Chonat, Satheesh, Mary Risinger, Haripriya Sakthivel, Omar Niss, Jennifer A. Rothman, Loan Hsieh, Stella T. Chou, et al. “Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis.” Front Physiol 10 (2019): 1331. https://doi.org/10.3389/fphys.2019.01331.
       Full Text  Link to Item
    • Tan, Queenie K-G, Heidi Cope, Rebecca C. Spillmann, Nicholas Stong, Yong-Hui Jiang, Marie T. McDonald, Jennifer A. Rothman, et al. “Further evidence for the involvement of EFL1 in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features.” Cold Spring Harb Mol Case Stud 4, no. 5 (October 2018). https://doi.org/10.1101/mcs.a003046.
       Full Text  Link to Item
    • Grace, Rachael F., Jenny M. Despotovic, Carolyn M. Bennett, James B. Bussel, Michelle Neier, Cindy Neunert, Shelley E. Crary, et al. “Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.” Am J Hematol 93, no. 7 (July 2018): 882–88. https://doi.org/10.1002/ajh.25110.
       Full Text  Link to Item
    • Grace, Rachael F., Paola Bianchi, Eduard J. van Beers, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, Jenny M. Despotovic, et al. “Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.” Blood 131, no. 20 (May 17, 2018): 2183–92. https://doi.org/10.1182/blood-2017-10-810796.
       Full Text  Link to Item
    • Borst, Alexandra J., Debra L. Sudan, Laura A. Wang, Michael J. Neuss, Jennifer A. Rothman, and Thomas L. Ortel. “Bleeding and thrombotic complications of pediatric liver transplant.” Pediatr Blood Cancer 65, no. 5 (May 2018): e26955. https://doi.org/10.1002/pbc.26955.
       Full Text  Link to Item
    • Allen, Taryn M., Lindsay M. Anderson, Jennifer A. Rothman, and Melanie J. Bonner. “[Formula: see text]Executive functioning and health-related quality of life in pediatric sickle cell disease.” Child Neuropsychol 23, no. 8 (November 2017): 889–906. https://doi.org/10.1080/09297049.2016.1205011.
       Full Text  Link to Item
    • Cancio, Maria I., Banu Aygun, David H. K. Chui, Jennifer A. Rothman, J Paul Scott, Jeremie H. Estepp, and Jane S. Hankins. “The clinical severity of hemoglobin S/Black (A γδβ)0 -thalassemia.” Pediatr Blood Cancer 64, no. 11 (November 2017). https://doi.org/10.1002/pbc.26596.
       Full Text  Link to Item
    • Reiter, Audra, Henry Rice, and Jennifer Rothman. “LONG-TERM CLINICAL AND HEMATOLOGIC OUTCOMES OF SPLENECTOMY IN CHILDREN WITH CONGENITAL HEMOLYTIC ANEMIA.” Pediatric Blood & Cancer 63 (June 1, 2016): S57–S57.
       Link to Item
    • Estepp, Jeremie H., Chiara Melloni, Courtney D. Thornburg, Paweł Wiczling, Zora Rogers, Jennifer A. Rothman, Nancy S. Green, et al. “Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.” J Clin Pharmacol 56, no. 3 (March 2016): 298–306. https://doi.org/10.1002/jcph.598.
       Full Text  Link to Item
    • Wang, Hsin-Hsiao Scott, Katherine W. Herbst, Jennifer A. Rothman, Nirmish R. Shah, John S. Wiener, and Jonathan C. Routh. “Trends in Sickle Cell Disease-related Priapism in U.S. Children's Hospitals.” Urology 89 (March 2016): 118–22. https://doi.org/10.1016/j.urology.2015.11.023.
       Full Text  Link to Item
    • Ware, Russell E., Barry R. Davis, William H. Schultz, R Clark Brown, Banu Aygun, Sharada Sarnaik, Isaac Odame, et al. “Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.” Lancet 387, no. 10019 (February 13, 2016): 661–70. https://doi.org/10.1016/S0140-6736(15)01041-7.
       Full Text  Open Access Copy  Link to Item
    • Luchtman-Jones, Lori, Sara Pressel, Lee Hilliard, R Clark Brown, Mary G. Smith, Alexis A. Thompson, Margaret T. Lee, et al. “Effects of hydroxyurea treatment for patients with hemoglobin SC disease.” Am J Hematol 91, no. 2 (February 2016): 238–42. https://doi.org/10.1002/ajh.24255.
       Full Text  Link to Item
    • Englum, Brian R., Jennifer Rothman, Sarah Leonard, Audra Reiter, Courtney Thornburg, Mary Brindle, Nicola Wright, et al. “Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.” J Pediatr Surg 51, no. 1 (January 2016): 122–27. https://doi.org/10.1016/j.jpedsurg.2015.10.028.
       Full Text  Link to Item
    • Wood, John C., Alan R. Cohen, Sara L. Pressel, Banu Aygun, Hamayun Imran, Lori Luchtman-Jones, Alexis A. Thompson, et al. “Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.” Br J Haematol 172, no. 1 (January 2016): 122–30. https://doi.org/10.1111/bjh.13791.
       Full Text  Link to Item
    • Allewelt, Heather, Jessica Saricicek, Sachit Patel, and Jennifer Rothman. “BARRIERS TO IMPROVING ANALGESIA FOR VASO-OCCLUSIVE PAIN CRISES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE.” Pediatric Blood & Cancer 62 (June 1, 2015): 40–40.
       Link to Item
    • Rice, Henry E., Brian R. Englum, Jennifer Rothman, Sarah Leonard, Audra Reiter, Courtney Thornburg, Mary Brindle, et al. “Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.” Am J Hematol 90, no. 3 (March 2015): 187–92. https://doi.org/10.1002/ajh.23888.
       Full Text  Link to Item
    • Mize, Lindsay, Shelly Burgett, Julia Xu, Jennifer Rothman, and Nirmish Shah. “The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications.” Blood 124, no. 21 (December 6, 2014).
       Link to Item
    • Zimmerman, Sarah P., Jennifer A. Rothman, Jessica L. Hansen, Molly M. Rusin, Matthew A. Bertone, and Harvey J. Hamrick. “Systemic loxoscelism in a nonendemic area: a diagnostic challenge for the unsuspecting physician.” Clin Pediatr (Phila) 53, no. 11 (October 2014): 1098–1100. https://doi.org/10.1177/0009922813512419.
       Full Text  Link to Item
    • Leonard, Sarah, Jennifer Rothman, Nirmish Shah, Courtney Thornburg, and Henry Rice. “CURRENT PRACTICE PATTERNS FOR PARTIAL VERSUS TOTAL SPLENECTOMY IN PEDIATRIC PATIENTS WITH CONGENITAL HEMOLYTIC ANEMIA.” Pediatric Blood & Cancer 61 (May 1, 2014): S92–S92.
       Link to Item
    • Mouttalib, Sofia, Henry E. Rice, Denise Snyder, Justin S. Levens, Audra Reiter, Pauline Soler, Jennifer A. Rothman, and Courtney D. Thornburg. “Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.” Pediatr Blood Cancer 59, no. 1 (July 15, 2012): 100–104. https://doi.org/10.1002/pbc.24057.
       Full Text  Link to Item
    • Shah, Nirmish, Daniel Landi, Radhika Shah, Jennifer Rothman, Laura M. De Castro, and Courtney D. Thornburg. “Complications of implantable venous access devices in patients with sickle cell disease.” Am J Hematol 87, no. 2 (February 2012): 224–26. https://doi.org/10.1002/ajh.22230.
       Full Text  Link to Item
    • Rothman, Jennifer A., Rupali Das, David T. Teachey, Michele E. Paessler, and Kim E. Nichols. “Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice.” Pediatr Blood Cancer 57, no. 7 (December 15, 2011): 1239–43. https://doi.org/10.1002/pbc.23226.
       Full Text  Link to Item
    • Mouttalib, Sofia, Denise Snyder, Justin Levens, Pauline Soler, Jennifer Rothman, Courtney Thornburg, and Henry Rice. “USE OF INTERNET-BASED REGISTRY FOR EVALUATION OF PARTIAL AND TOTAL SPLENECTOMY IN SICKLE CELL DISEASE.” Pediatric Blood & Cancer 56, no. 6 (June 1, 2011): 911–911.
       Link to Item
    • Talaat, Kawsar R., Jennifer A. Rothman, Jeffrey I. Cohen, Mariarita Santi, John K. Choi, Miguel Guzman, Robert Zimmerman, et al. “Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.” Pediatr Blood Cancer 53, no. 6 (December 2009): 1120–23. https://doi.org/10.1002/pbc.22185.
       Full Text  Link to Item
    • Impens, A. J., J. Rothman, E. Schiopu, J. C. Cole, J. Dang, N. Gendrano, R. C. Rosen, and J. R. Seibold. “Sexual activity and functioning in female scleroderma patients.” Clinical and Experimental Rheumatology 27, no. 3 SUPPL. 54 (November 9, 2009).
    • Schiopu, Elena, Vivien M. Hsu, Ann J. Impens, Jennifer A. Rothman, Deborah A. McCloskey, Julianne E. Wilson, Kristine Phillips, and James R. Seibold. “Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis.” J Rheumatol 36, no. 10 (October 2009): 2264–68. https://doi.org/10.3899/jrheum.090270.
       Full Text  Link to Item
    • Impens, A. J., J. Rothman, E. Schiopu, J. C. Cole, J. Dang, N. Gendrano, R. C. Rosen, and J. R. Seibold. “Sexual activity and functioning in female scleroderma patients.” Clin Exp Rheumatol 27, no. 3 Suppl 54 (May 2009): 38–43.
       Link to Item
    • Nunez-Cruz, Selene, WC Janice Yeo, Jennifer Rothman, Priti Ojha, Hamid Bassiri, Marisa Juntilla, Dominique Davidson, André Veillette, Gary A. Koretzky, and Kim E. Nichols. “Differential requirement for the SAP-Fyn interaction during NK T cell development and function.” J Immunol 181, no. 4 (August 15, 2008): 2311–20. https://doi.org/10.4049/jimmunol.181.4.2311.
       Full Text  Link to Item
    • Rao, Aarati, Jennifer Rothman, and Kim E. Nichols. “Genetic testing and tumor surveillance for children with cancer predisposition syndromes.” Curr Opin Pediatr 20, no. 1 (February 2008): 1–7. https://doi.org/10.1097/MOP.0b013e3282f4249a.
       Full Text  Link to Item
    • Bassiri, Hamid, W. C. Janice Yeo, Jennifer Rothman, Gary A. Koretzky, and Kim E. Nichols. “X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.” Immunol Res 42, no. 1–3 (2008): 145–59. https://doi.org/10.1007/s12026-008-8048-7.
       Full Text  Link to Item
    • Chonat, Satheesh, Mary Risinger, Haripriya Sakthivel, Omar Niss, Jennifer A. Rothman, Loan Hsieh, Stella T. Chou, et al. “The Spectrum of SPTA1-Associated Hereditary Spherocytosis.” Frontiers in Physiology 10 (n.d.). https://doi.org/10.3389/fphys.2019.00815.
       Full Text

  • Book Sections

    • Greiner, R. J., S. Peterson-Carmichael, J. A. Rothman, K. W. Gow, R. F. Tamburro, and R. Barfield. “Care of the oncology patient in the picu.” In Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems, 343–61, 2014. https://doi.org/10.1007/978-1-4471-6416-6_24.
       Full Text

  • Conference Papers

    • Robles, Joanna, Marissa Just, Ashley Frazier, Karan Kumar, Andrew Yazman, Heather McLean, Jennifer Rothman, and Kristy Pahl. “VTE IN HOSPITALIZED PEDIATRIC PATIENTS: IMPLEMENTING A RISK ASSESSMENT TOOL.” In Pediatric Blood & Cancer, 67:S59–S59. WILEY, 2020.
       Link to Item
    • Addonizio, Kathryn, Hanny Al-Samkari, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A. Thompson, Kevin H. M. Kuo, et al. “Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency.” In Blood, 134:3515–3515. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-125248.
       Full Text
    • Al-Samkari, Hanny, Eduard J. van Beers, D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, et al. “Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency.” In Blood, 134:949–949. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-125352.
       Full Text
    • Boscoe, Audra N., Yan Yan, Elizabeth Hedgeman, Eduard J. van Beers, Hanny Al-Samkari, Wilma Barcellini, Stefan W. Eber, et al. “Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency.” In Blood, 134:2175–2175. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-123069.
       Full Text
    • Just, Marissa A., Joanna Robles, Karan R. Kumar, Andrew Yazman, Jennifer A. Rothman, and Kristy S. Pahl. “A Retrospective Review of Hospital-Acquired Venous Thromboembolism at a Large Pediatric Tertiary Care Center.” In Blood, 134:3471–3471. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-129398.
       Full Text
    • Nannes, Caleb, Jennifer Rothman, Addison Gross, and Susan Kreissman. “IMPROVING NUTRITIONAL SUPPORT FOR PEDIATRIC HEMATOLOGY & ONCOLOGY PATIENTS.” In Pediatric Blood & Cancer, Vol. 66. WILEY, 2019.
       Link to Item
    • Chonat, Satheesh, Mary Risinger, Haripriya Sakthivel, Omar Niss, Jennifer A. Rothman, Loan Hsieh, Stella T. Chou, et al. “The Spectrum of SPTA1-Associated Hereditary Spherocytosis.” In Front Physiol, 10:815, 2019. https://doi.org/10.3389/fphys.2019.00815.
       Full Text  Link to Item
    • Van Beers, Eduard J., Kevin H. M. Kuo, D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, et al. “Health Related Quality of Life and Fatigue in Patients with Pyruvate Kinase Deficiency.” In Blood, 132:4807–4807. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-113206.
       Full Text
    • Grace, Rachael F., Robert J. Klaassen, Jennifer A. Rothman, Kerry Hege, Ellis J. Neufeld, Carolyn M. Bennett, Michele Lambert, et al. “Clinical Characteristics and Quality of Life of Children with ITP Starting Second Line Treatments: Data from the ITP Consortium of North America ICON1 Study.” In Blood, 128:249–249. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.249.249.
       Full Text
    • Lambert, Michele P., Rachael F. Grace, Cindy Neunert, Jenny M. Despotovic, Rukhmi Bhat, Yves D. Pastore, George R. Buchanan, et al. “Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP.” In Blood, 128:1008–1008. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.1008.1008.
       Full Text
    • Leraas, Harold J., Jina Kim, Zhifei Sun, Uttara P. Nag, Brian D. Ezekian, Reed W. Kamyszek, Brian C. Gulack, et al. “Postoperative Venous Thromboembolism in Children Is Increased in Setting of Cancer or Infection.” In Blood, 128:2391–2391. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.2391.2391.
       Full Text
    • Ware, Russell E., Adam Lane, William H. Schultz, Hamayun Imran, Margaret T. Lee, Matthew M. Heeney, Clark Brown, et al. “Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial.” In Blood, 128:1019–1019. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.1019.1019.
       Full Text
    • Bianchi, Paola, Elisa Fermo, Kimberly Lezon-Geyda, Patrick G. Gallagher, D Holmes Morton, Wilma Barcellini, Bertil Glader, et al. “Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants.” In Blood, Vol. 126. AMER SOC HEMATOLOGY, 2015.
       Link to Item
    • Grace, Rachael F., D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Jenny M. Depsotovic, Christine M. Knoll, Hassan M. Yaish, et al. “The Phenotypic Spectrum of Pyruvate Kinase Deficiency (PKD) from the PKD Natural History Study (NHS): Description of Four Severity Groups By Anemia Status.” In Blood, Vol. 126. AMER SOC HEMATOLOGY, 2015.
       Link to Item
    • Ware, Russell E., Barry R. Davis, William H. Schultz, Clark Brown, Banu Aygun, Sharada A. Sarnaik, Isaac Odame, et al. “TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia.” In Blood, Vol. 126. AMER SOC HEMATOLOGY, 2015.
       Link to Item
    • Grace, R., W. Barcellini, S. Eber, J. Kunz, J. Despotovic, A. Thompson, D. H. Morton, et al. “CATEGORIZATION OF CLINICAL SEVERITY IN PYRUVATE KINASE DEFICIENCY (PKD) IN AN INTERNATIONAL, OBSERVATIONAL COHORT.” In Haematologica, 100:130–31. FERRATA STORTI FOUNDATION, 2015.
       Link to Item
    • Morton, D. H., C. Knoll, J. Rothman, B. Glader, E. Neufeld, W. Barcellini, S. Eber, et al. “THE CLINICAL FEATURES AND TREATMENT OF IRON OVERLOAD IN PYRUVATE KINASE DEFICIENCY (PKD): DATA FROM THE PKD NATURAL HISTORY STUDY (NHS).” In Haematologica, 100:588–588. FERRATA STORTI FOUNDATION, 2015.
       Link to Item
    • Willen, Shaina, Nirmish Shah, Courtney Thornburg, and Jennifer Rothman. “Timing of the Initiation of Hydroxyurea and Hematologic Outcomes in Patients with Sickle Cell Disease (SCD).” In Blood, 120:1004–1004. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.1004.1004.
       Full Text
    • Rothman, Jennifer, Shelly Burgett, Russell E. Ware, and Courtney Thornburg. “Hydroxyurea Reduces Conversion From Conditional to Abnormal TCD Velocities In Children with Sickle Cell Anemia (SCA).” In Blood, 116:123–24. AMER SOC HEMATOLOGY, 2010.
       Link to Item
    • Shah, Neil, Hagop Kantarjian, Andreas Hochhaus, Jorge E. Cortes, M Brigid Bradley-Garelik, Chao Zhu, and Michele Baccarani. “Dasatinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) In the DASISION Trial: 18-Month Follow-up.” In Blood, 116:206–206. American Society of Hematology, 2010. https://doi.org/10.1182/blood.v116.21.206.206.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.